Bristol Myers Squibb posted higher first-quarter revenue boosted by its portfolio of newer treatments for heart and blood conditions. https://t.co/Bz8u2pGmz1 ...

Merck & Co. reports first-quarter sales that beat Wall Street estimates as demand ramps up for newer products https://t.co/bmsrGoTb8x ...

AstraZeneca will invest £300 million ($405 million) in UK life sciences, Prime Minister Keir Starmer told Parliament, a deal he said was enabled by the trade deal between Britain and the US https://t.co/Jam4BClCts ...

Haleon's first quarter was weaker than expected, hurt by weak demand for over-the-counter cold and flu medicines https://t.co/BQSkePFDRR ...

AstraZeneca reported rises in revenue and core earnings for the first quarter, saying growing sales of its cancer and rare-disease drugs lifted results. https://t.co/EXX8ym1TJZ ...

Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals as it looks at deals to expand its footprint globally, people familiar with the matter said https://t.co/d7GF0qnHxz ...

Eli Lilly continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer portfolio https://t.co/OKVACn0UJq ...

Eli Lilly agreed to buy closely held Ajax for as much as $2.3 billion in cash to gain promising experimental medicines for blood cancers https://t.co/Ytffetf5qn ...

Sun Pharma agreed to acquire New York-listed women’s health-care company Organon, in what is likely to be one of the biggest India outbound deals in years https://t.co/30lkj6q6rR ...

Picture the scenario. You walk into McDonald's to grab lunch when you're met with an endless line of hungry customers. The understaffed employees are running around to catch up.You order a meal, wait for a painfully long 20 minutes. When you get home, you find that your order was slightly messed up. You asked for no cheese on your sandwich.The soda was not a diet, and there's no ketchup to go with your fries. Now, your meal may be ruined, but I think all of us can live with that. Now, compare it to this ima ...